RBC Capital Raises Price Target Following eBay's (EBAY) 3c EPS Beat

Mizuho Securities Remains Neutral Following a 3c EPS Beat by eBay (EBAY)

October 22, 2015 9:43 AM EDT

Mizuho Securities reiterated a Neutral rating on eBay (NASDAQ: EBAY), and cut the price target to $29.00 (from $30.00), following the company's 3Q15 earnings results. eBay reported 3Q15 revenue of $2.1b, which was slightly better than the Street estimates of $2.09b. Non-GAAP EPS came in at... More

Pre-Open Stock Movers 10/22: (OCLR) (PFPT) (TXN) (MCD) Higher; (RLYP) (CYH) (APOL) (VRX) Lower (more...)

October 22, 2015 9:30 AM EDT

Relypsa (NASDAQ: RLYP) 31.6% LOWER; reversing earlier gains following FDA approval of Veltassa. Declines appear related to concerns about the drug's label. Analysts at Morgan Stanley described the label as "highly restrictive" and said it will probably limit demand.

Community Health Systems (NYSE: CYH) 23.3% LOWER; announced preliminary financial and operating results for the three... More

S&P 500 ends at highest in two months; Alphabet up after hours

October 22, 2015 7:00 AM EDT

By Caroline Valetkevitch

(Reuters) - The S&P 500 closed at its highest in two months on Thursday as stronger-than-expected earnings from several top companies, including McDonald's, relieved investors' concerns about the profit outlook.

Buying accelerated after the close, with broad gains in tech and other companies that reported results, including Alphabet (NASDAQ: GOOGL), up 9.6 percent at $746.78, and Microsoft (NASDAQ: MSFT), up 7.2 percent at $51.50. Amazon (NASDAQ: AMZN) rose 10.6 percent to $623.75 after it posted results.

Nasdaq 100 futures jumped after the close... More

eBay's (EBAY) First Standalone Seen as 'Solid'; Cowen Reaffirms at 'Market Perform'

October 22, 2015 6:43 AM EDT

Cowen and Company affirms eBay (Nasdaq: EBAY) with a Market Perform rating and $27 price target following Q3 results reported on Wednesday night.

Analyst John Blackledge commented, EBAY reported solid results its first quarter post the PYPL spin, as revenue was essentially in line, while EPS beat due to prior restructuring efforts. Standalone... More

After-Hours Movers 10/21: (OCLR) (TXN) (EBAY) Higher; (CYH) (NOW) (AXP) Lower (more...)

October 21, 2015 6:09 PM EDT

Oclaro (NASDAQ: OCLR) 20.4% HIGHER; reported preliminary results for its first quarter of fiscal year 2016. The Company announced that it expects first quarter results to exceed its previously provided financial guidance. The Company's financial guidance was last provided on August 4, 2015. For the first quarter of fiscal year 2016, Oclaro expects: Revenues to be approximately $87.5 million, at the high end of the range previously provided. (The Street sees $85.6 million.)

Community Health Systems (NYSE: CYH) 15.5% LOWER; announced preliminary financial and... More

Market Wrap: Citron Slams Valeant; Biden Pulls Out of Presidential Race; Twitter Clipps on Downgrade

October 21, 2015 5:28 PM EDT

Market wrap for October 21st

End of the Day: S&P 500 down 11.8 to 2,018.94; Dow Jones down 48.5 to 17,168.61; Nasdaq down 40.9 to 4,840.12

Market Brief: Markets were largely mixed most of Wednesday's trading session, but ended lower as the slump in Valeant shares weighed on the pharmaceutical segment.

Joe Biden said he wouldn't be running for U.S. president.

Western Digital affirmed recent speculation and announced a deal to acquire SanDisk.

CIT CEO John Thain announced his retirement.

Several key earnings announcements... More

UPDATE: eBay (EBAY) Tops Q3 EPS by 3c

October 21, 2015 4:14 PM EDT

(Updated - October 21, 2015 4:16 PM EDT)

eBay (NASDAQ: EBAY) reported Q3 EPS of $0.43, $0.03 better than the analyst estimate of $0.40. Revenue for the quarter came in at $2.1 billion versus the consensus estimate of $2.09 billion.

Business Outlook

Fourth quarter year 2015 The company expects net... More

Wall St. declines; Valeant, healthcare weigh

October 21, 2015 7:08 AM EDT

By Caroline Valetkevitch

(Reuters) - U.S. stocks fell on Wednesday as a sharp drop in Valeant Pharmaceuticals hit the healthcare space, while the energy sector dropped along with oil prices.

Valeant Pharmaceuticals' (NYSE: VRX) U.S.-listed shares plunged to an intraday low of $88.50 on record volume after a short-seller accused the company of using specialty pharmacies to inflate its revenue.

The company denied the allegation, and later investor Bill Ackman said he increased his Valeant stake by about 2 million shares. The stock pared losses to end down 19.2 percent at $118.61,... More